Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Immix Biopharma Inc’s stock clocked out at $5.23, down -0.95% from its previous closing price of $5.28. In other words, the price has decreased by -$0.95 from its previous closing price. On the day, 0.75 million shares were traded. IMMX stock price reached its highest trading level at $5.3799 during the session, while it also had its lowest trading level at $5.15.
Ratios:
To gain a deeper understanding of IMMX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 10 ’25 when Rachman Ilya M bought 746 shares for $6.67 per share. The transaction valued at 4,976 led to the insider holds 1,141,683 shares of the business.
Morris Gabriel S bought 770 shares of IMMX for $5,067 on Dec 10 ’25. The CFO now owns 291,429 shares after completing the transaction at $6.58 per share. On Sep 17 ’25, another insider, Rachman Ilya M, who serves as the CEO and Chairman of the company, bought 2,500 shares for $2.02 each. As a result, the insider paid 5,050 and bolstered with 1,140,937 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMMX now has a Market Capitalization of 275597568 and an Enterprise Value of 160771296.
Stock Price History:
The Beta on a monthly basis for IMMX is 0.32, which has changed by 1.2255318 over the last 52 weeks, in comparison to a change of 0.15196204 over the same period for the S&P500. Over the past 52 weeks, IMMX has reached a high of $7.73, while it has fallen to a 52-week low of $1.34. The 50-Day Moving Average of the stock is 14.42%, while the 200-Day Moving Average is calculated to be 86.83%.
Shares Statistics:
It appears that IMMX traded 957.48K shares on average per day over the past three months and 869010 shares per day over the past ten days. A total of 52.70M shares are outstanding, with a floating share count of 33.53M. Insiders hold about 36.37% of the company’s shares, while institutions hold 5.49% stake in the company. Shares short for IMMX as of 1765756800 were 1746822 with a Short Ratio of 1.82, compared to 1763078400 on 1186085. Therefore, it implies a Short% of Shares Outstanding of 1746822 and a Short% of Float of 4.2299999999999995.
Earnings Estimates
A comprehensive evaluation of Immix Biopharma Inc (IMMX) is underway, with the input of 1.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.14 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.68 and -$0.77 for the fiscal current year, implying an average EPS of -$0.73. EPS for the following year is -$0.64, with 2.0 analysts recommending between -$0.64 and -$0.65.
